Group 1 - The stock of Kangtong Medical increased by 1.53% on September 8, with a trading volume of 38.57 million yuan [1] - On the same day, the financing buy amount was 3.29 million yuan, while the financing repayment was 11.10 million yuan, resulting in a net financing buy of -7.81 million yuan [1] - As of September 8, the total financing and securities lending balance for Kangtong Medical was 42.95 million yuan, accounting for 2.81% of its circulating market value, indicating a high level compared to the past year [1] Group 2 - As of August 29, the number of shareholders for Kangtong Medical was 7,804, a decrease of 10.20% from the previous period [2] - The average circulating shares per person increased by 11.35% to 8,078 shares [2] - For the first half of 2025, Kangtong Medical reported a revenue of 265 million yuan, a year-on-year decrease of 39.29%, and a net profit attributable to the parent company of -8.40 million yuan, a year-on-year decrease of 154.53% [2] Group 3 - Since its A-share listing, Kangtong Medical has distributed a total of 48.99 million yuan in dividends [3]
港通医疗9月8日获融资买入328.94万元，融资余额4294.50万元